IART (integralife.com) Earnings per share growth this year
Integra LifeSciences maintains its leadership in neurosurgery by scaling sales of Codman instruments. The annual EPS change metric on the GURU.Markets chart shows a value of 4.70. Balanced revenues from tissue regeneration minimize regulatory risks, while business success relies on government healthcare budgets and strict adherence to quality standards during production.
Financial and market metric breakdowns for Integra LifeSciences (IART)
- stock value and consensus price forecast:
- business market valuation indicators:
- book capitalization information:
- debt and solvency information:
Debt to Capital Integra LifeSciences|IART - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio integralife.com|IART - Company Aggregate Debts|Debts to Net Assets Integra LifeSciences Inc.|IART - Company Long-Term Debts|Company Current Liabilities Integra LifeSciences|Quick Ratio integralife.com
- net income and valuation multiples indicators:
IART - Company Net Income|Expected Profit Integra LifeSciences|IART - Price to Earnings Ratio|Future Price to Earnings Multiple Integra LifeSciences Inc.|IART - PEG Multiple|Company Value to EBITDA Integra LifeSciences Inc.|IART - Profit before payment of interest, taxes and amortization|Net earnings per share for the trailing year Integra LifeSciences|IART - Net earnings per share for the last 12 months|Quarterly EPS earnings growth integralife.com|IART - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Integra LifeSciences
Fundamental valuation:IART - Integra LifeSciences Corp
Integra LifeSciences operates in the stable neurosurgery and regenerative medicine segment, where the updating of implant product lines directly impacts financial returns. The relative EPS YoY trend measures the annual dynamics of net profit per share, allowing investors to assess the real growth rate of the business by stripping out quarterly fluctuations and avoiding the purchase of an overvalued asset at the peak of the curve.
Direct competitors
Earnings per share growth rate in current year Boston Scientific Corp (BSX)|EW (Edwards Lifesciences Corp) - Earnings growth in current year|Earnings per share growth this year RMD (ResMed Corporation)|Net earnings per share growth this year PODD (Insulet Corporation)|ZBH (Zimmer Biomet Holdings, Inc.) - Earnings per share increase in current year|Earnings per share growth in current year CooperCompanies COO|ALGN - Net earnings per share growth this year|Globus Medical Corp - Earnings growth in current year|Earnings per share growth rate in current year TransMedics Group|ATEC: Earnings growth in current year|Earnings per share growth this year AORT|ENOV (Enovis) - Earnings growth in current year|Establishment Labs Corp (ESTA) - Expected net earnings per share growth this year|Earnings growth in current year BBNX|Net earnings per share growth this year IRADIMED Inc. IRMD|Earnings growth in current year EMBC (Embecta Corp.)|Earnings growth in current year tandemdiabetes.com TNDM|AXGN - Earnings per share growth in current year|SIBN: Earnings per share growth in current year|OFIX (Orthofix International) - Net earnings per share growth this year|Bioventus Global - Earnings per share increase in current year|KIDS (OrthoPediatrics Corp) - Earnings growth in current year|Earnings per share growth rate in current year treace.com TMCI|Earnings per share growth in current year Strata Critical Medical (SRTA)|Carlsmed, Inc. (CARL) - Net earnings per share change in current year|RxSight Corp - Net earnings per share growth this year|Earnings growth in current year ClearPoint Neuro Inc. CLPT|Stereotaxis, Inc. - Earnings growth in current year|Expected net earnings per share growth this year neurostar.com STIM|Sight Sciences (SGHT) - Earnings per share growth in current year|Earnings per share trend in current year OBIO (orchestrabiomed.com)|Earnings per share growth in current year Anika Therapeutics Inc.|Net earnings per share growth this year InspireMD Inc. (NSPR)|Earnings growth in current year ZJYL|VANI - Earnings per share growth rate in current year|Earnings per share growth in current year Xtant Medical XTNT|NMTC: Earnings per share growth this year|MODD: Net earnings per share growth this year|Myomo Inc - Net earnings per one share growth for the current year|COCH: Earnings growth in current year|VVOS - Expected net earnings per share growth this year|Earnings per share growth in current year enVVeno Medical Corp.|Earnings per share growth this year SINT (SINTX Technologies)|Net earnings per share growth this year TNON (Tenon Medical, Inc)|Net earnings per one share growth for the current year LFWD|Earnings growth in current year AMIX (Autonomix Medical)|invobioscience.com (IVF) - Earnings per share growth rate in current year|Bone Biologics Corp - Earnings growth in current year|Net earnings per share change in current year Axonics Inc. (AXNX)|Biolase, Inc. (BIOL) - Earnings per share growth in current year|Dynatronics - Earnings per share increase in current year|FNA (Paragon 28 Inc.) - Earnings growth in current year|Earnings growth in current year INVO Bio
